Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yuki Sato
Institution:
Kobe City Medical Center General Hospital
Observed institution:
Kobe City Medical Center General Hospital
ORCID:
0000-0002-7829-7524
Observed ORCID:
0000-0002-7829-7524
OpenAlex ID:
A5137105864
Targeting driver mutations in lung cancer with interstitial pneumonia: A nationwide study in Japan
2026
·
Satoshi Ikeda
, Takashi Ogura
, et al.
·
European Journal of Cancer
·
2
Atezolizumab vs durvalumab for extensive-stage small cell lung cancer in Japan: a real-world comparative analysis of costs and clinical outcomes
2026
·
Katsuya Hirano
, Akito Hata
, et al.
·
Japanese Journal of Clinical Oncology
Phase II study of multidisciplinary therapy combined with pembrolizumab for patients with synchronous oligometastatic non-small cell lung cancer: TRAP-OLIGO study (WJOG11118L).
2026
·
Hideyuki Harada
, Taichi Miyawaki
, et al.
·
Journal of Clinical Oncology
Randomized phase II study of amivantamab + lazertinib versus afatinib in patients with uncommon/compound EGFR -mutated non-small cell lung cancer (WJOG17323L: AGEHA study).
2026
·
Taichi Miyawaki
, Takehito Shukuya
, et al.
·
Journal of Clinical Oncology
PDF
Prognostic stratification using baseline objective clinical information in patients with stage IV lung cancer receiving best supportive care alone as initial treatment: A multicenter retrospective study (WJOG20824L).
2026
·
Shunichi Kataoka
, Takehito Shukuya
, et al.
·
Journal of Clinical Oncology
Final overall survival analysis of the APPLE study: atezolizumab and platinum-pemetrexed with or without bevacizumab for metastatic nonsquamous non-small cell lung cancer
2026
·
Yoshimasa Shiraishi
, Junji Kishimoto
, et al.
·
Lung Cancer
Efficacy and Safety of First-Line Ramucirumab Plus Erlotinib for EGFR L858R-Mutated NSCLC in Real-World Practice: A Retrospective Multicenter REAL-SPEED Analysis
2026
·
Masashi Ishihara
, Takahisa Kawamura
, et al.
·
JTO Clinical and Research Reports
PDF
Perioperative Nivolumab in Resectable Non‐Small Cell Lung Cancer: A Subanalysis of Japanese Patients From CheckMate 77T
2025
·
Fumihiro Tanaka
, Yasutaka Watanabe
, et al.
·
Cancer Science
PDF
Show more works
View as search
Works count:
8
Citation count:
2
H-index:
1
I10-index:
Year
Topic
Type